We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bionic 'Super Lenses' Could Correct Vision Deterioration

By HospiMedica International staff writers
Posted on 22 Sep 2008
Bionic ocular implants that correct both long and shortsightedness, allowing patients to throw away their glasses for good, could be available in as little as five years.

Researchers at Aston University (Birmingham, United Kingdom) are developing so-called "bionic surgery” which promises treatment of both long and shortsightedness. More...
The new implantable intraocular lens (IOL), which is attached to the muscles of the eye, would be extra-flexible, allowing it to be formed into a different shape by the eye's muscles, so that the eye can focus on both near and distant objects, and all points in between (a process known as accommodation). The new surgery is also claimed to prevent future cataracts in those implanted with the lens, since the IOL replaces the natural, biological lens. The surgical procedure is similar to cataract surgery.

"As you get older, the lens of your eye hardens and is no longer able to change its shape and focus, so you have to hold something further away to read it; by 45, you can no longer stretch your arms far enough and you need glasses,” said lead investigator optometrist Professor James Wolffsohn, Ph.D. "Everyone over 45 would benefit because it means they will be able to see distance and near absolutely naturally. It is the true definition of a bionic eye. You are replacing something that has aged in the eye with a technological structure.”

While using an IOL implant to correct vision clouded by a cataract or presbyopia is similar to the new lens being developed, there is no accommodation. The eye's natural lens is replaced by either a monofocal intraocular lens (used to give clear point focus either at a distance or close up), or multifocal IOLs, which allow correction of vision at all distances. However, in both cases, deterioration in vision requires repeat intraocular surgery and replacement of the lens. The new lens would be a permanent implant.

Related Links:
Aston University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.